
Rivaroxaban in prevention of stroke in elderly patients with non-valvular atrial fibrillation
Author(s) -
I. S. Yavelov
Publication year - 2020
Publication title -
kardiologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.159
H-Index - 16
eISSN - 2412-5660
pISSN - 0022-9040
DOI - 10.18087/cardio.n892
Subject(s) - rivaroxaban , atrial fibrillation , medicine , warfarin , stroke (engine) , cardiology , randomized controlled trial , mechanical engineering , engineering
Data regarding efficacy and safety of direct oral anticoagulant rivaroxaban in prevention of stroke in elderly polymorbid patients with non-valvular atrial fibrillation are presented. In this aspect results of randomized clinical trial in direct comparison of rivaroxaban and warfarin in patients with non-valvular atrial fibrillation ROCKET-AF are discussed. Results of rivaroxaban use in elderly patients in real medical practice are also considered.